Prebiotics and synbiotics in ulcerative colitis

Scandinavian Journal of Gastroenterology

Volumn 52, Issue 4, 2017, Pages 477-485

  Laurell, Axel ^a   Sjöberg, Klas ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

IBD; microbiota; prebiotics; synbiotics; ulcerative colitis

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE; GALACTOSE OLIGOSACCHARIDE; LACTULOSE; PREBIOTIC AGENT; RESVERATROL; SHORT CHAIN FATTY ACID; SYNBIOTIC AGENT; YOGHURT; INULIN; OLIGOSACCHARIDE;

ANAEROSTIPES CACCAE; BIFIDOBACTERIUM LONGUM; DIETARY FIBER; EUBACTERIUM; EUBACTERIUM RECTALE; FOOD; HUMAN; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; ROSEBURIA INTESTINALIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULCERATIVE COLITIS; WEIGHT REDUCTION; ANIMAL; ANIMAL MODEL; COLON; DIET THERAPY; DRUG EFFECTS; MICROBIOLOGY; MICROFLORA; MOUSE; RAT;

ANIMALS; COLITIS, ULCERATIVE; COLON; HUMANS; INULIN; MICE; MICROBIOTA; MODELS, ANIMAL; OLIGOSACCHARIDES; PREBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; SYNBIOTICS;

EID: 85010460623     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365521.2016.1263680     Document Type: Review

References (60)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.e42.
2. Kanai T, Matsuoka K, Naganuma M, et al. Diet, microbiota, and inflammatory bowel disease:lessons from Japanese foods. Korean J Intern Med. 2014;29:409–415.
3. Leone V, Chang EB, Devkota S., Diet, microbes, and host genetics:the perfect storm in inflammatory bowel diseases. J Gastroenterol. 2013;48:315–321.
4. Ohkusa T, Koido S., Intestinal microbiota and ulcerative colitis. J Infect Chemother. 2015;21:761–768.
5. Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63:1275–1283.
6. De Leon LM, Watson JB, Kelly CR., Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013;11:1036–1038.
7. Hill C, Guarner F, Reid G, et al. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506–514.
8. Bindels LB, Delzenne NM, Cani PD, et al. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol. 2015;12:303–310.
9. Khor B, Gardet A, Xavier RJ., Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–317.
10. Lichtenstein L, Avni-Biron I, Ben-Bassat O., Probiotics and prebiotics in Crohn’s disease therapies. Best Pract Res Clin Gastroenterol. 2016;30:81–88.
11. SBU. Utvärdering av metoder i hälso- och sjukvården:en handbok. 1st ed. Stockholm:Statens beredning för medicinsk utvärdering (SBU); 2013.
12. CONSORT. CONSORT 2010 [Internet]. c2010. [cited 2015 Aug 2]. Available from:http://www.consort-statement.org/consort-2010
13. Roberfroid MB, Van Loo JAE, Gibson GR., The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr. 1998;128:11–19.
14. Van den Abbeele P, Gérard P, Rabot S, et al. Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ Microbiol. 2011;13:2667–2680.
15. Sato T, Matsumoto K, Okumura T, et al. Isolation of lactate-utilizing butyrate-producing bacteria from human feces and in vivo administration of Anaerostipes caccae strain L2 and galacto-oligosaccharides in rat model. FEMS Microbiol Ecol. 2008;66:528–536.
16. Winkler J, Butler R, Symonds E., Fructo-oligosaccharide reduces inflammation in a dextran sodium sulphate mouse model of colitis. Dig Dis Sci. 2007;52:52–58.
17. Lara-Villoslada F, De Haro O, Camuesco D, et al. Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur J Nutr. 2006;45:418–425.
18. Hoentjen F, Welling GW, Harmsen HJM, et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis. 2005;11:977–985.
19. Johansson MEV, Gustafsson JK, Sjöberg KE, et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One. 2010;5:e12238.
20. Casellas F, Borruel N, Torrejón A, et al. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther. 2007;25:1061–1067.
21. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis:a randomised controlled pilot trial. Gut. 2005;54:242–249.
22. Siedner DL, Lashner BA, Brzezinski A, et al. An oral supplement enriched with fish oil, soluble fiber and antioxidants for corticosteroid sparing in ulcerative colitis:a randomised, controlled trial. Clin Gastroenterol Hepatol. 2005;3:358–369.
23. Bamba T, Kanauchi O, Andoh A, et al. A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis. J Gastroenterol Hepatol. 2002;17:818–824.
24. Kanauchi O, Fujiyama Y, Mitsuyama K, et al. Increased growth of Bifidobacterium and Eubacterium by germinated barley foodstuff, accompanied by enhanced butyrate production in healthy volunteers. Int J Mol Med. 1999;3:175–179.
25. Kanauchi O, Serizawa I, Araki Y, et al. Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment. J Gastroenterol. 2003;38:134–141.
26. Araki Y, Kanauchi O, Sugihara H, et al. Germinated barley foodstuff suppresses dextran sulphate experimental colitis in rats:the role of mast cells. Int J Mol Med. 2007;19:257–262.
27. Araki Y, Fujiyama Y, Andoh A, et al. The dietary combination of germinated barley foodstuff plus Clostridium butyricum suppresses the dextran sulphate sodium-induced experimental colitis in rats. Scand J Gastroenterol. 2000;35:1060–1067.
28. Kanauchi O, Oshima T, Andoh A, et al. Germinated barley foodstuff ameliorates inflammation in mice with colitis through modulation of mucosal immune system. Scand J Gastroenterol. 2008;43:1346–1352.
29. Mitsuyama K, Saiki T, Kanauchi O, et al. Treatment of ulcerative colitis with germinated barley foodstuff feeding:a pilot study. Aliment Pharmacol Ther. 1998;12:1225–1230.
30. Kanauchi O, Suga T, Tochihara M, et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff:first report of a multicentre open control trial. J Gastroenterol. 2002;37(Suppl XIV):67–72.
31. Kanauchi O, Mitsuyama K, Homma T, et al. Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff:multi-center open trial. Int J Mol Med. 2003;12:701–704.
32. Faghfoori Z, Shakerhosseini R, Navai L, et al. Effects of an oral supplementation of germinated barley foodstuff on serum CRP level and clinical signs in patients with ulcerative colitis. Health Promot Perspect. 2014;4:116–121.
33. Faghfoori Z, Navai L, Shakerhosseini R, et al. Effects of an oral supplementation of germinated barley foodstuff on serum tumor necrosis factor-α, interleukin-6 and -8 in patients with ulcerative colitis. Ann Clin Biochem. 2011;48:233–237.
34. Hanai H, Kanauchi O, Mitsuyama K, et al. Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int J Mol Med. 2004;13:643–647.
35. Vénica CI, Bergamini CV, Rebechi SR, et al. Galacto-oligosaccharides formation during manufacture of different varieties of yogurt. Stability through storage. LWT-Food Sci Technol. 2015;63:198–205.
36. Holma R, Juvonen P, Asmawi MZ, et al. Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats. Scand J Gastroenterol. 2002;37:1042–1047.
37. Davis LMG, Martínez I, Walter J, et al. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol. 2010;144:285–292.
38. Ishikawa H, Matsumoto S, Ohashi Y, et al. Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis:a randomised controlled study. Digestion. 2011;84:128–133.
39. Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther. 2004;20:1133–1141.
40. Chen X, Zuo Q, Hai Y, et al. Lactulose:an indirect antioxidant ameliorating inflammatory bowel disease by increasing hydrogen production. Med Hypotheses. 2011;76:325–327.
41. Mao B, Li D, Zhao J, et al. In vitro fermentation of lactulose by human gut bacteria. J Agric Food Chem. 2014;62:10970–10977.
42. Vanhoutte T, De Preter V, De Brandt E, et al. Molecular monitoring of the faecal microbiota of healthy human subjects during the administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol. 2006;72:5990–5997.
43. Rumi G, Tsubouchi R, Okayama M, et al. Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Dig Dis Sci. 2004;49:1466–1472.
44. Hafer A, Krämer S, Duncker S, et al. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease:a pilot study. BMC Gastroenterol. 2007;7:36.
45. Diaz-Gerevini GT, Repossi G, Dain A, et al. Beneficial action of resveratrol:how and why? Nutrition. 2016;32:174–178.
46. Bode LM, Bunzel D, Huch M, et al. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am J Clin Nutr. 2013;97:295–309.
47. Samsamikor M, Daryani NE, Asl PR, et al. Anti-inflammatory effects of resveratrol in patients with ulcerative colitis:a randomized, double-blind, placebo-controlled pilot study. Arch Med Res. 2015;46:280–285.
48. Sánchez-Fidalgo S, Cárdeno A, Villegas I, et al. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol. 2010;633:78–84.
49. Larossa M, Yañéz-Gascón MJ, Selma MV, et al. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J Agric Food Chem. 2009;57:2211–2220.
50. Etxeberria U, Arias N, Boqué N, et al. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose fed rats. J Nutr Biochem. 2015;26:652–660.
51. Ghouri Y, Richards DM, Rahimi EF, et al. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol. 2014;7:473–487.
52. Derikx LAAP, Dielemann LA, Hoentjen F., Probiotics and prebiotics in ulcerative colitis. Best Pract Res Clin Gastroenterol. 2016;30:55–71.
53. Macfarlane GT, Macfarlane S., Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int. 2012;95:50–60.
54. Rajilić-Stojanović M, Shanahan F, Guarner F, et al. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis. 2013;19:481–488.
55. Png CW, Lindén SK, Gilshenan KS, et al. Mycolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105:2420–2428.
56. Fischer H, Holst E, Karlsson F, et al. Altered microbiota in microscopic colitis. Gut 2015;64:1185–1186.
57. Morse A, Dlusskaya EA, Valcheva R, et al. T2041 Prebiotic mixture of inulin plus oligofructose is effective adjunct therapy for treatment of mild to moderate ulcerative colitis. Gastroenterology. 2010;138(Suppl. 1):S-619.
58. Guslandi M. Efficacy of a symbiotic product during clinical relapse of ulcerative colitis. J Clin Gastroenterol. 2011;45:475–476.
59. Haskey N, Dahl WJ., Synbiotic therapy improves quality of life and reduces symptoms in paediatric ulcerative colitis. Infant Child Adolesc Nutr. 2009;1:88–93.
60. Kanauchi O, Mitsuyama K, Andoh A, et al. Beneficial effects of prebiotics, germinated barley foodstuff, in the long term treatment of ulcerative colitis:a multi-center open control study. Gastroenterology. 2003;124(Suppl. 1):A260.